|
CANF
|
Can-Fite Biopharma Ltd Sponsored ADR (Israel)
|
US
|
AMEX
|
|
CCXI
|
ChemoCentryx, Inc.
|
US
|
NASDAQ
|
|
CEMI
|
Chembio Diagnostics, Inc.
|
US
|
NASDAQ
|
|
CGEM
|
Cullinan Management, Inc.
|
US
|
NASDAQ
|
|
CGEN
|
Compugen Ltd.
|
US
|
NASDAQ
|
|
CHRS
|
Coherus BioSciences, Inc.
|
US
|
NASDAQ
|
|
CKPT
|
Checkpoint Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CLDX
|
Celldex Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CMMB
|
ChemomAb Therapeutics Ltd.
|
US
|
NASDAQ
|
|
CNTB
|
Connect Biopharma Holdings Limited
|
US
|
NASDAQ
|
|
COYA
|
Coya Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CRVS
|
Corvus Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
CVM
|
Cel-Sci Corporation
|
US
|
AMEX
|
|
DBVT
|
DBV Technologies S.A.
|
US
|
NASDAQ
|
|
ELEV
|
Elevation Oncology, Inc.
|
US
|
NASDAQ
|
|
ENLV
|
Enlivex Therapeutics Ltd.
|
US
|
NASDAQ
|
|
EQ
|
Equillium, Inc.
|
US
|
NASDAQ
|
|
ERNA
|
Eterna Therapeutics Inc.
|
US
|
NASDAQ
|
|
ERYP
|
Erytech Pharma S.A.
|
US
|
NASDAQ
|
|
FBIO
|
Fortress Biotech, Inc.
|
US
|
NASDAQ
|